Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Merrick RIS, LLC
  2. Issuer Name and Ticker or Trading Symbol
MERGE HEALTHCARE INC [MRGE]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last)
(First)
(Middle)
350 NORTH ORLEANS STREET,, 10TH FLOOR
3. Date of Earliest Transaction (Month/Day/Year)
05/11/2012
(Street)

CHICAGO, IL 60654
4. If Amendment, Date Original Filed(Month/Day/Year)
6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 05/11/2012   P   211,300 A $ 2.8 (1) 31,946,237 D  
Common Stock               500,000 I See Footnote (2)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Merrick RIS, LLC
350 NORTH ORLEANS STREET,
10TH FLOOR
CHICAGO, IL 60654
    X    
FERRO MICHAEL W JR
350 NORTH ORLEANS STREET,
10TH FLOOR
CHICAGO, IL 60654
  X   X    

Signatures

 /s/ Mark Harris, as Attorney-in-Fact   05/11/2012
**Signature of Reporting Person Date

 /s/ Mark Harris, as Attorney-in-Fact   05/11/2012
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices between $2.73 and $2.94. The reporting persons undertake to provide to Merge Healthcare Incorporated ("Merge"), any stockholder of Merge, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price set forth in this footnote.
(2) These shares were issued to Merrick Healthcare Solutions, LLC, an Indiana limited liability company ("Merrick Healthcare"), as consideration for the purchase price of the acquisition by Merge of the assets of, and relating to, the Olivia Greets business line previously owned by Merrick Healthcare. These shares were subsequently transferred from Merrick Healthcare to Merrick Ventures, LLC, a private investment firm ("Merrick Ventures"). Both Merrick Healthcare and Merrick RIS, LLC, a Delaware limited liability company ("Merrick RIS"), are majority-owned subsidiaries of Merrick Ventures. Merrick RIS is not a beneficial owner of these shares.
 
Remarks:
The reporting persons are Merrick RIS, a ten percent owner, and Michael W. Ferro, Jr., the Chairman of the Board of Directors of Merge and a ten percent owner ("Mr. Ferro").  Mr. Ferro is also the Chairman and Chief Executive Officer of Merrick RIS and Merrick Ventures. Mr. Ferro and trusts for the benefit of Mr. Ferro's family members beneficially own a majority of the equity interests in Merrick RIS and Merrick Ventures.  As a result of the foregoing, Mr. Ferro indirectly controls all shares of Merge Common Stock owned by Merrick RIS and Merrick Ventures.  Mr. Ferro disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. The address of the reporting persons is 350 North Orleans Street, 10th Floor, Chicago, Illinois 60654.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.